BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 309904)

  • 1. Immune response to a mammary adenocarcinoma. VI. Blocking of tumor-specific cell-mediated cytotoxicity by antibodies to the cytotoxic lymphocyte.
    Huber SA; Lucas ZJ
    J Immunol; 1978 Dec; 121(6):2490-6. PubMed ID: 309904
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune response to a mammary adenocarcinoma. IV. Blocking of cell-mediated cytolysis by immunoglobulins binding to immune lymphocytes.
    Huber SA; Lucas ZJ
    J Immunol; 1977 Aug; 119(2):726-36. PubMed ID: 328781
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune response to a mammary adenocarcinoma. V. Sera from tumor-bearing rats contain multiple factors blocking cell-mediated cytotoxicity.
    Huber SA; Lucas ZJ
    J Immunol; 1978 Dec; 121(6):2485-9. PubMed ID: 722081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in kinetic parameters of lysis by syngeneic and allogeneic T lymphocytes immune to the same tumor.
    Huber SA; Lucas ZJ
    J Immunol; 1978 Dec; 121(6):2270-7. PubMed ID: 309897
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune response to a syngeneic mammary adenocarcinoma. II. In vitro generation of cytotoxic lymphocytes.
    Kuperman O; Fortner GW; Lucas ZJ
    J Immunol; 1975 Nov; 115(5):1277-81. PubMed ID: 51887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic determinants in a virus-induced mouse mammary tumor recognized by cell-mediated immune assays.
    Lopez PF; Parks WP; Lopez DM
    J Natl Cancer Inst; 1984 Mar; 72(3):725-32. PubMed ID: 6199544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response to a syngeneic mammary adenocarcinoma. III. Development of memory and suppressor functions modulating cellular cytotoxicity.
    Kuperman O; Fortner GW; Lucas ZJ
    J Immunol; 1975 Nov; 115(5):1282-7. PubMed ID: 1176776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-specific suppressor cells induced by immunization with spleen cells from tumor-bearing animals.
    Huber SA; Bigi G; Lucas ZJ
    Cancer Res; 1980 Oct; 40(10):3477-83. PubMed ID: 6449281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic adoptive transfer of immunity to 13762A rat mammary adenocarcinoma.
    Boyer CM; Kreider JW; Bartlett GL
    Cancer Res; 1981 Jun; 41(6):2394-400. PubMed ID: 6972251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cycling of immune responses to a syngeneic murine mammary adenocarcinoma.
    Huber SA; Bigi G; Lucas ZJ
    Cancer Res; 1980 Oct; 40(10):3484-90. PubMed ID: 6449282
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the induction and expression of T cell-mediated immunity. X. Inhibition by Lyt 2,3 antisera of cytotoxic T lymphocyte-mediated antigen-specific and -nonspecific cytotoxicity: evidence for the blocking of the binding between T lymphocytes and target cells and not the post-binding cytolytic steps.
    Fan J; Ahmed A; Bonavida B
    J Immunol; 1980 Dec; 125(6):2444-53. PubMed ID: 6159409
    [No Abstract]   [Full Text] [Related]  

  • 12. Possible evidence for antibody-dependent macrophage-mediated cytotoxicity directed against murine adenocarcinoma cells in vivo.
    Haskill JS; Fett JW
    J Immunol; 1976 Nov; 117(5 Pt.2):1992-8. PubMed ID: 993593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct evidence for the role of LGL in the inhibition of experimental tumor metastases.
    Barlozzari T; Leonhardt J; Wiltrout RH; Herberman RB; Reynolds CW
    J Immunol; 1985 Apr; 134(4):2783-9. PubMed ID: 3871818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytotoxic response of rats bearing multicellular spheroids of adenocarcinoma 13762].
    Pelletier G; Osmond L; Laflamme G
    Union Med Can; 1981 Jul; 110(7):669-72. PubMed ID: 7292798
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppressor lymphokine produced by rat T-cells in response to syngeneic mammary adenocarcinoma 13762A.
    Christensen ND; Kreider JW; Horetsky RL
    Cancer Res; 1988 Feb; 48(4):943-9. PubMed ID: 2962735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response to a syngeneic mammary adenocarcinoma. I. Comparison of kinetics of tumor cell growth and cytotoxic responses in syngeneic and allogeneic rats.
    Fortner GW; Kuperman O; Lucas ZJ
    J Immunol; 1975 Nov; 115(5):1269-76. PubMed ID: 1080776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of serial transplantation on the immunological-clinical correlates of BALB/cfC3H mouse mammary tumors.
    Hager JC; Miller FR; Heppner GH
    Cancer Res; 1978 Aug; 38(8):2492-500. PubMed ID: 667845
    [No Abstract]   [Full Text] [Related]  

  • 18. Splenic alterations during mammary tumorigenesis: diverse effects on different immune parameters.
    Paul RD; Ghaffar A; Sigel MM; Charyulu V; Lopez DM
    Anticancer Res; 1981; 1(2):63-9. PubMed ID: 6214206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target cell - substratum interaction. I. Effect of primed lymphocytes on a rat mammary adenocarcinoma tumor cell line.
    David GS; Wiglesworgh CM
    Immunol Commun; 1978; 7(3):337-52. PubMed ID: 77840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of H-2 histocompatibility on generation of cell-mediated cytotoxicity against virus-induced mammary tumors in C3H mice.
    Stutman O
    Transplant Proc; 1977 Mar; 9(1):1153-5. PubMed ID: 194369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.